Where Things Stand on Drug Pricing at the Halfway Point of 2023 | White & Case LLP

While only slightly past the midway point of 2023, it has already been a busy year for developments in drug pricing. Notably, CMS released its final guidance in preparation for price...

Related Keywords

Ohio ,United States ,Dayton ,Cathy Kelly ,John Stanford ,Joseph Walker ,Daniel Orourke ,Pharma Ceos ,Mark Terry ,Joe Grogan ,Senate Finance Committee ,B Drug Pricing Program ,Congress Must Fix ,Trademark Office ,Department Of Health ,Merck Co Inc ,York Summer Associates Gwendolyn Johnson ,Dayton Area Chamber ,Commission Statement Concerning Reliance On Prior Advocacy ,Centers For Medicare Medicaid Services ,Republican House Oversight Committee ,Syngenta ,Human Services ,Us Chamber ,Health Care Price Transparency ,Medicare Drug Price Negotiation Program ,Committee On Oversight ,Inflation Reduction Act ,Medicaid Services ,Medicare Drug Price Negotiation ,Fifth Amendment ,Pricing Legislation Scheduled ,Preserve Access ,Affordable Generics ,Biosimilars Act ,Affordable Prescriptions ,Patients Act ,Interagency Patent Coordination ,Improvement Act ,United States Patent ,Prescription Pricing ,People Act ,Lawmakers Continue ,Seek New ,House Oversight Committee ,Pharmacy Benefit Manager Reform Act ,Drug Price Transparency ,Medicaid Act ,Pharmacy Benefit Manager Transparency Act ,Before Middlemen ,Pharmacy Benefits Manager Accountability Act ,Preserving Rules Ordered ,Entities Covered Through ,Drug Pricing ,Transparency Act ,Will Expand ,Hot Seat ,Danielo Rourke ,Eugene Hutchinson ,Five Drug Pricing Issues ,Case Insight Alert ,Alnylam Acting ,Rationally In Halting Second Orphan Indication ,Pink Sheet ,Wall Street Journal ,Molecule Penalty ,Kartik Rai ,Cryptic Patent Reform Through ,Medicare Will Parry Manufacturer Efforts ,Sidestep Price Negotiation ,Guidance Says ,Medicare Negotiation Workarounds ,Big Pharma Pricing Strategies ,Small Molecule Drugs ,Revised Guidance ,Social Security Act ,Initial Price Applicability Year ,Historic Announcement ,First Selected Drugs ,New Powers ,Negotiate Drug Prices ,Federal Government ,New Drug Price Powers ,Preliminary Injunction ,Patent Coordination ,Trade Commission Statement Concerning Reliance ,Related Advocacy Statements ,Price Transparency ,Benefit Manager Reform Act ,Benefit Manager Transparency Act ,Benefits Manager Accountability Act ,Marshall Introduce Bipartisan Legislation ,Bring Down ,Prescription Drugs ,Pharmacy Benefit Managers ,Pharmaceutical Markets ,Frazier Joins Growing List ,Attacking Drug Rebates ,Bio Space ,Before Middlemen Act ,Senate Finance Committee Votes ,Impose Drug Pricing Standards ,Fierce Healthcare ,Manager Accountability Act ,Care Price Transparency Act ,